Combined use of statins and inhibitors of arginase l-norvaline for correcting endotoksin-inducing endotelial dysfunction
Using of the combined use of non-selective inhibitor of arginase L-norvaline with simvastatin, atorvastatin, rosuvastatin and rosuvastatin nanopartikulirovanny on background modeling endotoxin-induced disease, the introduction of strain 603 Staphylococcusaureus shows ekdotelio- and cardioprotective...
Main Authors: | T. A. Denisyuk, M. V. Pokrovsky, G. A. Lazareva, T. G. Pokrovskaya, M. V. Korokin, O. A. Osipova, A. I. Lazarev, L. N. Sernov, S. A. Demchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Healthcare of the Russian Federation. “Kuban State Medical University”
2016-02-01
|
Series: | Кубанский научный медицинский вестник |
Subjects: | |
Online Access: | https://ksma.elpub.ru/jour/article/view/445 |
Similar Items
-
Correction of endotoxin-induced endothelial dysfunction by recombinant erythropoetin and inhibitors of HMG-Co-A-reductase
by: T. A. Denisyuk, et al.
Published: (2015-12-01) -
Endothelium and cardioprotectiv effects of HMG Co-A reductase in combination with L-arginin endotelial dysfunction in modeling
by: T. A. Denisyuk, et al.
Published: (2016-04-01) -
STUDY OF ENDOTHELIAL PROTECTIVE AND OSTEOPROTECTIVE PROPERTIES OF ROSUVASTATIN, L-NORVALINE AND THEIR COMBINATIONS IN EXPERIMENTAL OSTEOPOROSIS
by: M. S. SOBOLEV, et al.
Published: (2017-12-01) -
First discovered positive effect of L-norvaline on the volume of small intestine tissues necrosis in a model of segmental mesenteric thrombosis in rats
by: Sergey A. Alekhin, et al.
Published: (2023-05-01) -
Endotelioand cardioprotective effects of HMG-Co-A reductase in endotoksininducing endotelial dysfunction
by: T. A. Denisuk, et al.
Published: (2016-06-01)